- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Tumor Grade in Canada
Total 1156 results
-
Novartis PharmaceuticalsCompletedSolid TumorsSpain, Canada, France, Denmark, Netherlands, Germany, Norway
-
PfizerCompletedGastrointestinal Stromal TumorUnited States, Australia, Belgium, Italy, Singapore, Spain, Switzerland, United Kingdom, Canada, France, Netherlands
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
University Health Network, TorontoMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Malignant Melanoma | Squamous Cell Cancer of Head and NeckCanada
-
AHS Cancer Control AlbertaTerminatedLymphoma | Cancer | Solid Tumor | Brain CancerCanada
-
Sumitomo Pharma America, Inc.TerminatedGastrointestinal Stromal TumorsCanada
-
University Health Network, TorontoUniversity of British Columbia; McMaster University; University of Toronto; Canadian...Completed
-
Ottawa Hospital Research InstituteUnknown
-
Ontario Clinical Oncology Group (OCOG)PfizerCompletedVenous Thromboembolism | Brain TumorsUnited States, Canada, Australia, Italy
-
Hoffmann-La RocheCompleted
-
SanofiTerminatedMalignant Solid TumorFrance, Spain, Australia, Belgium, Italy, United Kingdom, Taiwan, Estonia, Netherlands, Korea, Republic of, United States, Canada, Germany
-
Symphogen A/SCompletedLymphoma | Solid Tumor | Metastatic CancerCanada, United States
-
London Health Sciences CentreUniversity of Western Ontario, Canada; London Regional Cancer Program, CanadaTerminated
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
Sanotize Research and Development corp.Completed
-
Instylla, Inc.Recruiting
-
University Health Network, TorontoCompleted
-
Sunnybrook Health Sciences CentreUnity Health TorontoCompleted
-
University of ManitobaCancerCare ManitobaRecruitingGlioblastoma MultiformeCanada
-
AHS Cancer Control AlbertaRecruiting
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Wilms Tumor and Other Childhood Kidney Tumors | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Neuroectodermal Tumor and other conditionsUnited States, Canada, Australia
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Canada, Israel
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
University of British ColumbiaBritish Columbia Centre for Disease ControlTerminated
-
Bristol-Myers SquibbCompletedPan TumorUnited States, Puerto Rico, Italy, Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Netherlands, Poland, Romania, Singapore, Spain, United Kingdom
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, France, Korea, Republic of, Canada, Singapore
-
Kinnate BiopharmaRecruitingMelanoma | Non-small Cell Lung Cancer | Solid Tumor, AdultUnited States, Australia, France, Spain, Taiwan, Korea, Republic of, China, Netherlands
-
Université de SherbrookeRecruitingGlioblastoma Multiforme | RelapseCanada
-
University Health Network, TorontoSinai Health SystemWithdrawn
-
AHS Cancer Control AlbertaWithdrawn
-
Bassam AbdulkarimPfizer; Canadian Cancer Society (CCS)UnknownGlioblastoma MultiformeCanada
-
University of AlbertaCapital Health, CanadaCompletedMalignant Gliomas, Glioblastoma MultiformeCanada
-
Maisonneuve-Rosemont HospitalHippocrate Research & DevelopmentUnknownGastrointestinal Stromal TumorsCanada
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Small Intestine Cancer | Brain and Central Nervous System Tumors | Lymphoproliferative DisorderUnited States, Canada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompleted
-
University Health Network, TorontoCompletedTrigeminal Neuralgia | Schwannoma | Arteriovenous MalformationCanada
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
McGill UniversityRecruiting
-
University Health Network, TorontoWithdrawnFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Endometrioid Tumor | TP53 MutationCanada
-
Simon DobsonMinistry of Health, British ColumbiaCompletedCervical Cancer | Genital WartsCanada
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, Canada, United Kingdom
-
NCIC Clinical Trials GroupCompletedColorectal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificCanada
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruiting
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
Sunnybrook Health Sciences CentreCentre hospitalier de l'Université de Montréal (CHUM); Exactis Innovation; Princess...RecruitingOvarian Cancer | Triple Negative Breast Cancer | High Grade Serous CarcinomaCanada
-
Giselle ShollerY-mAbsRecruitingHigh-risk NeuroblastomaUnited States, Canada